Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors

Seminars in Immunology

Volumn 18, Issue 3, 2006, Pages 159-166

  Deng, Lu ^a   Mariuzza, Roy A ^a  

^a UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

Author keywords

Crystal structure; MHC; Natural killer cell receptor; Virus

Indexed keywords

CD94 ANTIGEN; GLYCOPROTEIN; HLA A2 ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; IMMUNOGLOBULIN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LECTIN; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D;

AMINO TERMINAL SEQUENCE; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CELL FUNCTION; CELL ISOLATION; CELL STRUCTURE; CRYSTAL STRUCTURE; CYTOLYSIS; HUMAN; HUMAN CYTOMEGALOVIRUS; HYDROGEN BOND; HYDROPHILICITY; HYDROPHOBICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR RECOGNITION; NATURAL KILLER CELL; NONHUMAN; PROTEIN DOMAIN; REVIEW; STRUCTURE ANALYSIS; T LYMPHOCYTE; VIRUS INFECTION;

ANIMALS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LIGANDS; MICE; MODELS, MOLECULAR; RECEPTORS, IMMUNOLOGIC;

EID: 33744511084     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2006.03.004     Document Type: Review

References (51)

1. McQueen K.L., and Parham P. Variable receptors controlling activation and inhibition of NK cells. Curr Opin Immunol 14 (2002) 615-621
2. Plougastel B.F.M., and Yokoyama W.M. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 3 (2003) 304-316
3. Kärre K., Ljunggren H.G., Piontek G., and Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 319 (1986) 675-678
4. Ljunggren H.G., and Kärre K. In search of the "missing self": MHC molecules and NK cell recognition. Immunol Today 11 (1990) 237-244
5. Natarajan K., Dimasi N., Wang J., Mariuzza R.A., and Margulies D.H. Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu Rev Immunol 20 (2002) 853-885
6. Vivier E., Tomasello E., and Paul P. Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition?. Curr Opin Immunol 14 (2002) 306-311
7. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., and Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296 (2002) 1323-1326
8. Smith H.R., Heusel J.W., Mehta I.K., Kim S., Dorner B.G., Naidenko O.V., et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 99 (2002) 8826-8831
9. Derosiers M.-P., Kielczewska A., Loredi-Osti J.-C., Adam S.G., Makrigiannis A.P., Lemiex S., et al. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat Genet 37 (2005) 593-599
10. Fan Q.R., Mosyak L., Winter C.C., Wagtmann N., Long E.O., and Wiley D.C. Structure of the inhibitory receptor for human natural killer cells resembles hematopoietic receptors. Nature 389 (1997) 96-100
11. Snyder G.A., Brooks A.G., and Sun P.D. Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2. Proc Natl Acad Sci USA 96 (1999) 3864-3869
12. Maenaka K., Juji T., Stuart D.I., and Jones E.Y. Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I. Structure 7 (1999) 391-398
13. Saulquin X., Gastinel L.N., and Vivier E. Crystal structure of the human natural killer cell activator receptor KIR2DS2 (CD158j). J Exp Med 197 (2003) 933-938
14. Boyington J.C., Motyka S.A., Schuck P., Brooks A.G., and Sun P.D. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405 (2000) 537-543
15. Fan Q.R., Long E.O., and Wiley D.C. Crystal structure of the human natural killer inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol 2 (2001) 452-460
16. de Vos A.M., Ultsch M., and Kossiakoff A.A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255 (1992) 306-312
17. Somers W., Ultsch M., De Vos A.M., and Kossiakoff A.A. The X-ray structure of a growth hormone-prolactin receptor complex. Nature 372 (1994) 478-481
18. Rajakopalan S., and Long E.O. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J Exp Med 185 (1997) 1523-1528
19. Zappacosta F., Borrego F., Brooks A.G., Parker K.C., and Coligan J.E. Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis. Proc Natl Acad Sci USA 94 (1997) 6313-6318
20. Rudolph M.G., Luz J.G., and Wilson I.A. Structural and thermodynamic correlates of T cell signaling. Annu Rev Biophys Biomol Struct 31 (2002) 121-149
21. Borges L., and Cosman D. LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells. Cytokine Growth Factor Rev 11 (2000) 209-217
22. Cella M., Nakajima H., Facchetti F., Hoffmann T., and Colonna M. ILT receptors at the interface between lymphoid and myeloid cells. Curr Top Microbiol Immunol 251 (2000) 161-166
23. Chapman T.L., Haikema A.P., and Bjorkmann P.J. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral MHC homolog UL18. Immunity 11 (1999) 603-611
24. Shiroishi M., Tsumoto K., Amano K., Shirakihara Y., Colonna M., Braud V.M., et al. Human inhibitory receptors ILT2 and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci USA 100 (2003) 8856-8861
25. Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peterson L., et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7 (1997) 273-282
26. Chapman T.L., Heikema A.P., West Jr. A.P., and Bjorkman P.J. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT-2). Immunity 13 (2000) 727-736
27. Willcox B.E., Thomas L.M., and Bjorkman P.J. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat Immunol 4 (2003) 913-919
28. Anderson S.K., Ortaldo J.R., and McVicar D.W. The ever-expanding Ly49 gene family: repertoire and signaling. Immunol Rev 181 (2001) 79-89
29. Franksson L., Sundbäck J., Achour A., Bernlind J., Glas R., and Kärre K. Peptide dependency and selectivity of the NK inhibitory receptor Ly-49C. Eur J Immunol 29 (1999) 2748-2758
30. Hanke T., Takizawa H., McMahon C.W., Busch D.H., Pamer E.G., Miller J.D., et al. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11 (1999) 67-77
31. Tormo J., Natarajan K., Margulies D.H., and Mariuzza R.A. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature 402 (1999) 623-631
32. b. Nat Immunol 4 (2003) 1213-1222
33. Dimasi N., Sawicki M.W., Reineck L.A., Li Y., Natarajan K., Margulies D.H., et al. Crystal structure of the Ly49I natural killer cell receptor reveals variability in dimerization mode within the Ly49 family. J Mol Biol 320 (2002) 573-585
34. Matsumoto N., Mitsuki M., Tajima K., Yokoyama W.M., and Yamamoto K. The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand. J Exp Med 193 (2001) 147-158
35. 2-microglobulin. J Biol Chem 277 (2002) 1433-1442
36. McFarland B.J., Kortemme T., Yu S.F., Baker D., and Strong R.K. Symmetry recognizing asymmetry: analysis of the interactions between the C-type lectin-like immunoreceptor NKG2D and MHC class I-like ligands. Structure 11 (2003) 411-422
37. Groh V., Steinle A., Bauer S., and Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science 279 (1998) 1737-1740
38. Groh V., Rhinehart R., Secrist H., Bauer S., Grabstein K.H., and Spies T. Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB. Proc Natl Acad Sci USA 96 (1999) 6879-6884
39. Cerwenka A., Bakker A.B., McClanahan T., Wagner J., Wu J., Phillips J.H., et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12 (2000) 721-727
40. Diefenbach A., Jamieson A.M., Liu S.D., Shastri N., and Raulet D.H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 1 (2000) 119-126
41. Cosman D., Mullberg J., Sutherland C.L., Chin W., Armitage R., Fanslow W., et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14 (2001) 123-133
42. Lodoen M., Ogasawara K., Hamerman J.A., Arase A., Houchins J.P., Mocarski E.S., et al. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med 197 (2003) 1245-1253
43. Lodoen M.B., Abenes G., Umamoto S., Houchins J.P., Liu F., and Lanier L.L. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions. J Exp Med 200 (2004) 1075-1081
44. Krmpotic A., Hasan M., Loewendorf A., Saulig T., Halenius A., Lenac T., et al. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by mouse cytomegalovirus gene m145. J Exp Med 201 (2005) 211-220
45. Wolan D.W., Teyton L., Rudolph M.G., Villmow B., Bauer S., Busch D.H., et al. Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 Å. Nat Immunol 2 (2001) 248-254
46. Li P., McDermott G., and Strong R.K. Crystal structure of RAE-1β and its complex with the activating immunoreceptor NKG2D. Immunity 16 (2002) 77-86
47. Li P., Morris D.L., Willcox B.E., Steinle A., Spies T., and Strong R.K. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat Immunol 2 (2001) 443-451
48. Radaev S., Rostro B., Brooks A.G., Colonna M., and Sun P. Conformational plasticity revealed by the co-crystal structure of the activating NK receptor NKG2D and its MHC-like ligand ULBP. Immunity 15 (2001) 1039-1049
49. Li P., Willie S.T., Bauer S., Morris D.L., Spies T., and Strong R.K. Crystal structure of the MHC class I homolog MICA, a γδ T cell ligand. Immunity 10 (1999) 577-584
50. McFarland B.J., and Strong R.K. Thermodynamic analysis of degenerate recognition by the NKG2D immunoreceptor: not induced fit but rigid adaptation. Immunity 19 (2003) 803-812
51. Natarajan K., Hicks A., Mans J., Robinson H., Guan R., Mariuzza R.A., et al. Crystal structure of the murine cytomegalovirus MHC-I homolog m144. J Mol Biol 358 (2006) 157-171